It’s just a jump to the left
U.S. allows emergency use of first Covid-19 antibody drug
Good Entry Point for Amarin Stock? Not Just Yet, Says Analyst
5 Things Patient Advocates Want Pharma and the Healthcare Industry to Know
Biogen plunges 30% after FDA panel votes against Alzheimer’s drug
Top UK Scientists Warn "Many, Or All" COVID-19 Vaccine Projects Could Fail, First Gen "Likely To Be Imperfect"
Ocular Therapeutix Rises 7% On Stellar Results Backed By Dextenza
Digital therapies for opioid use disorder need more data, says ICER
This recession, banks are the good guys
German Doctors Urge Chancellor Merkel: Put An End To The COVID "Fear Machine"
Biden Taps BARDA Whistleblower Rick Bright for Covid-19 Advisory Board
Combative U.S. FDA panel votes against Biogen Alzheimer’s drug
AstraZeneca’s Heart Drug Gets FDA Nod For Stroke Reduction Use
Expert panel review on Alzheimer’s drug aducanumab becomes a one-day trial by fire as critics turn their guns on Biogen — and the FDA
Expert panel review on the Alzheimer’s drug aducanumab turns into a one-day trial by fire as critics turn their guns on Biogen — and the FDA
U.S. FDA panel votes successful study on Biogen Alzheimer’s drug cannot stand alone
Bharat Biotech – COVAXIN™
Study reveals strategy to create COVID-19 drugs to inhibit virus’s entry and replication
Aspirin to be tested as potential Covid-19 drug in UK study
Novo Nordisk Acquires Emisphere Tech in $1.8 Billion Deal
LSU health team wins Best 2020 Radiology Image award
3 Stocks RBC Says Are Ready to Rip Higher
Humanigen Spikes 13% On Positive Covid-19 Data For Lenzilumab
COVID-19 reveals how obesity harms the body in real time, not just over a lifetime
Delinquent electric bills from the pandemic are coming due – who will pay them?
Novartis’ Ilaris fails in late-stage COVID-19 trial
COVID-19 drug and vaccine patents are putting profit before people
Over a million people still filed initial unemployment claims last week with no COVID-19 relief in sight
Is It Time to Buy These 3 Dow Jones Stocks? Analysts Weigh In
COVID-19: Enzyme targeted by virus also influences gut inflammation